drugset / Trial / NCT05937100
New Vital Pulpotomy Medications in Primary Molars
RandomizedParallel-groupDouble-blindTreatment
Summary
Evaluate clinically and radiographically the effect of biodentine and hyaluronic acid (HA) versus formocresol (FC) as pulpotomy medications in primary molars.
Timeline
- Start
- 2023-05-01
- Primary completion
- 2025-07-01
- Completion
- 2025-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Biodentine | Other / unclassified | — | Topical |
| Comparator | Formocresol | Other / unclassified | 20 % | Topical |
| Subject | Hyaluronic acid gel | Unknown | — | Topical |